-
Afatinib Combined with Bevacizumab in the Treatment of Patients with Non-Small Cell Lung Cancer Harboring EGFR G719X, S768I or L861Q/P Mutations
25 Nov 2024 11:17 GMT
… non-small-cell lung cancer, afatinib, bevacizumab
Introduction … lung adenocarcinoma: the lung cancer mutation consortium experience. J Thorac … non-small cell lung cancer. Lung Cancer. 2015;87(2 … lung cancer: new evidence and treatment. Transl Lung Cancer Res …
-
The Potential Treatment Options and Combination Strategies of KRAS-Mutated Lung Cancer
14 Nov 2024 16:06 GMT
… therapeutic strategies available for lung cancer. Notably, combination … based on the lung cancer’s pathological type, … lung adenocarcinomas: the lung cancer mutation consortium experience. J Thorac … α with RAS in lung tumor maintenance. Cancer Cell. …
-
Dissecting the Clinical Characteristics and Treatment Outcomes Correlates of KRAS G12C-Mutated Non-Small Cell Lung Cancer
04 Oct 2024 05:38 GMT
… : the NCI’s lung cancer mutation consortium (LCMC). J Clin … National Swedish Lung Cancer Registry. Clin Lung Cancer. 2023;24 … non-small cell lung cancer outcomes. Lung Cancer. 2019;133 … lung cancer treated with first-line pembrolizumab monotherapy. Lung Cancer. …
-
KRASG12C Inhibitors in Non-Small Cell Lung Cancer: A Review
24 Aug 2024 10:55 GMT
… cell lung cancer (NSCLC) or small-cell lung cancer, based … Abbreviations
LC, Lung cancer; NSCLC, Non-small cell lung cancer; BMs, … adenocarcinoma: the NCI’s Lung Cancer Mutation Consortium (LCMC). J Clin … non-small cell lung cancer. Lung Cancer. 2020;146(1 …
-
Neoadjuvant Bests Adjuvant Therapy in Lung Cancer
25 Apr 2024 20:43 GMT
… by the New York Lung Cancer Foundation Summit: Call to … looked at critical issues in lung cancer therapy, from screening to … in the trial by the Lung Cancer Mutation Consortium, LCMC3, and this was … the preclinical studies in lung cancer and in breast cancer, …
-
Lung Cancer Research Foundation Names 2024 Evening of Innovation Gala Honoree
03 Apr 2024 06:32 GMT
… was a founder of The Lung Cancer Mutation Consortium (LCMC) in 2009. Fifteen … gala.
About the Lung Cancer Research Foundation (LCRF)
The Lung Cancer Research Foundation® ( … nonprofit organization dedicated to funding lung cancer research. For more information …
-
Lung Cancer Mutation Consortium LEADER Trial Enrolls 100th Patient
25 Oct 2023 08:09 GMT
… Lung Cancer Mutation Consortium (LCMC), facilitated by the Lung Cancer … Lung Cancer Research Foundation (LCRF)
The Lung Cancer … the Lung Cancer Mutation Consortium (LCMC)
The Lung Cancer Mutation Consortium (LCMC … #47;lung-cancer-mutation-consortium-leader-trial …
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) Demonstrated Strong and Durable Tumor Responses in Previously Treated HER2-mutant Advanced Lung Cancer in DESTINY-Lung02 Phase II Trial
11 Sep 2023 11:29 GMT
… of Lung Cancer (IASLC) 2023 World Conference on Lung Cancer (WCLC … improvements for people with lung cancer, including and beyond … A report from the Lung Cancer Mutation Consortium. Cancer. 2017; 123 … HER2-mutant advanced lung cancer: chemotherapies versus HER2 …
-
Neoadjuvant PD-1 Blockade in Non-Small Cell Lung Cancer: Current perspectives and Moving Forward
14 Feb 2023 16:06 GMT
… neoadjuvant chemotherapy in lung cancer patients is approximately … preoperative CT evaluation.
Lung Cancer Mutation Consortium 3 (LCMC3) is … lung cancer: early-stage non-small-cell lung cancer … patients with resected lung cancer after neoadjuvant chemotherapy. …
-
O'Donnell School of Public Health researchers use AI to seek new lung cancer treatments
09 Feb 2023 08:40 GMT
… with non-small cell lung cancers, a team led … Clinical Investigation, identified lung cancers most likely to respond … metastatic non-small cell lung cancers from 272 patients … studies conducted by the Lung Cancer Mutation Consortium (LCMC). The consortium …
About
© 1995-2024